Updates are available Correction dated 2019-07-16
Click to view Correction: https://doi.org/10.1007/s00520-019-04986-9
-
Authors
Hedden, Lindsay https://orcid.org/0000-0001-9552-1324
Pollock, Phil
Stirling, Bryan
Goldenberg, Larry
Higano, Celestia
-
Funding
Funding for this research was provided by:
Michael Smith Foundation for Health Research (16605)
Prostate Cancer Canada (PDF2016-1270)
- License Information
-
More Information
Article History
Received: 7 August 2018
Accepted: 6 June 2019
First Online: 25 June 2019
Change Date: 16 July 2019
Change Type: Correction
Change Details: The name of Stirling Bryan was incorrectly captured in the original manuscript.
Compliance with ethical standards
:
: Dr. Higano has received research grants from Aptevo, Aragon, Astellas, AstraZeneca, Bayer, Dendreon, Emergent, Genentech, Hoffman-La Roche, Medivation, Millenium, Sanofi, and Pfizer. She has served on the advisory board or in a consultancy role for Aptevo, Asana, Astellas, Bayer, Blue Earth Diagnostics, Churchill, Clovis, Dendreon, Endocyte, Ferring, Janssen, Medivation, MorphoSys, Orion, and Pfizer.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. Ethics approval for this retrospective analysis was obtained from the University of British Columbia’s Clinical Research Ethics Board (H16-03296).
